GLENMEDE TRUST CO NA - Astellas Pharma Inc ownership

Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 13 filers reported holding Astellas Pharma Inc in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of Astellas Pharma Inc
ValueSharesWeighting
Q1 2020$5,183,0000.0%301,2530.0%0.02%0.0%
Q4 2019$5,183,000
+19.6%
301,253
-1.0%
0.02%
+20.0%
Q3 2019$4,333,000
-0.3%
304,422
-0.2%
0.02%
+5.3%
Q2 2019$4,346,000
-5.3%
305,095
-0.4%
0.02%
-9.5%
Q1 2019$4,588,000
-34.7%
306,283
-44.3%
0.02%
-38.2%
Q4 2018$7,028,000
-26.6%
550,310
+0.2%
0.03%
-10.5%
Q3 2018$9,580,000
+14.7%
549,022
+0.3%
0.04%
+2.7%
Q2 2018$8,349,000
+19.7%
547,505
+0.1%
0.04%
+27.6%
Q1 2018$6,974,0000.0%546,9100.0%0.03%0.0%
Q4 2017$6,974,000
+13311.5%
546,910
+13120.0%
0.03%
Q3 2017$52,000
-99.1%
4,137
-99.1%
0.00%
-100.0%
Q2 2017$5,823,0000.0%442,7730.0%0.03%0.0%
Q1 2017$5,823,000
+1235.6%
442,773
+1309.7%
0.03%
+1300.0%
Q4 2016$436,000
-0.2%
31,409
+11.2%
0.00%0.0%
Q3 2016$437,000
-0.2%
28,2370.0%0.00%
-33.3%
Q2 2016$438,000
-82.0%
28,237
-84.5%
0.00%
-81.2%
Q1 2016$2,431,000
-54.4%
182,700
-50.6%
0.02%
-55.6%
Q4 2015$5,326,000
+68.9%
370,122
+51.3%
0.04%
+56.5%
Q3 2015$3,154,000
+525.8%
244,593
+590.2%
0.02%
+475.0%
Q2 2015$504,000
-11.1%
35,440
+2.4%
0.00%0.0%
Q1 2015$567,000
+13.4%
34,603
-2.9%
0.00%0.0%
Q4 2014$500,000
+265.0%
35,653
+283.9%
0.00%
+300.0%
Q3 2014$137,000
+813.3%
9,288
+702.8%
0.00%
Q2 2014$15,000
+400.0%
1,157
+370.3%
0.00%
Q4 2013$3,0002460.00%
Other shareholders
Astellas Pharma Inc shareholders Q1 2018
NameSharesValueWeighting ↓
RENAISSANCE GROUP LLC 391,745$5,438,8800.25%
Cassady Schiller Wealth Management, LLC 698$9,6670.01%
MAI Capital Management 19,087$264,3620.00%
SVB WEALTH LLC 10,472$145,0370.00%
RHUMBLINE ADVISERS 34,759$481,4080.00%
First Horizon Advisors, Inc. 114$1,5780.00%
Operose Advisors LLC 90$1,2470.00%
Russell Investments Group, Ltd. 783$10,8450.00%
PNC FINANCIAL SERVICES GROUP, INC. 166$2,2990.00%
View complete list of Astellas Pharma Inc shareholders